TEVA

Teva Pharmaceutical Industries Limited
D

TEVA

18.120
USD
-0.36
(-1.92%)
مغلق
حجم التداول
311,901
الربح لكل سهم
3
العائد الربحي
-
P/E
-121
حجم السوق
20,786,374,616
أصول ذات صلة
ABBV
ABBV
-3.140
(-1.49%)
207.490 USD
AMGN
AMGN
-5.12
(-1.74%)
288.47 USD
BMY
BMY
-0.765
(-1.60%)
47.125 USD
GSK
GSK
-0.560
(-1.39%)
39.630 USD
JNJ
JNJ
-0.860
(-0.48%)
178.390 USD
MRK
MRK
-2.040
(-2.33%)
85.330 USD
NVS
NVS
-1.950
(-1.54%)
124.990 USD
PFE
PFE
-0.735
(-2.84%)
25.135 USD
المزيد
الأخبار المقالات

العنوان: Teva Pharmaceutical Industries Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.